Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKCOM Regulatory News (KCOM)

  • There is currently no data for KCOM

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8 (OPD) (KCOM Group PLC)

3 May 2019 14:18

RNS Number : 0763Y
KCOM Group PLC
03 May 2019
 

FORM 8 (OPD)

 

PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER

Rules 8.1 and 8.2 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

KCOM GROUP PUBLIC LIMITED COMPANY ("KCOM")

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

 

 

N/A

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

KCOM

(d) Is the discloser the offeror or the offeree?

OFFEREE

(e) Date position held:

The latest practicable date prior to the disclosure

1 MAY 2019

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

 

N/A

 

 

2. POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates

 

Class of relevant security:

 

Ordinary shares in KCOM

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

NIL

NIL

(2) Cash-settled derivatives:

 

NIL

NIL

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

NIL

NIL

 

TOTAL:

NIL

NIL

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

(b) Rights to subscribe for new securities

 

Class of relevant security in relation to which subscription right exists:

NONE

Details, including nature of the rights concerned and relevant percentages:

N/A

 

 

3. POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

Details of any interests, short positions and rights to subscribe (including directors' and other employee options) of any person acting in concert with the party to the offer making the disclosure:

 

(a) Ordinary shares in KCOM owned by KCOM directors

 

Name

Number of ordinary shares in KCOM

Percentage of issued ordinary share capital in KCOM (per cent)(1)

Graham Sutherland

250,000

0.04839

Anna Bielby

17,016

0.00330

Peter Smith

50,000

0.00968

 

(1) Rounded to 5 decimal places

 

(b) Long Term Incentive Plan ("LTIP") awards held by KCOM executive directors

 

(i) LTIP award (in the form of an option in respect of KCOM ordinary shares) held by Graham Sutherland

 

Grant Date

Vesting Date

 

Exercise Price (£)

 

Outstanding

30 November 2018

29 November 2021

0.00

872,340

 

 

(ii) LTIP awards (in the form of options in respect of KCOM ordinary shares) held by Anna Bielby

 

Grant Date

Vesting Date

Exercise Price

(£)

 

Outstanding

15 February 2019

14 February 2022

0.00

 

404,494

11 July 2018

10 July 2021

0.00

75,078

7 July 2017

6 July 2020

0.00

29,050

 

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer making the disclosure or any person acting in concert with it:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

NONE

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer making the disclosure, or any person acting in concert with it, and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

NONE

 

 

(c) Attachments

 

Are any Supplemental Forms attached?

 

Supplemental Form 8 (Open Positions)

NO

Supplemental Form 8 (SBL)

NO

 

 

Date of disclosure:

3 May 2019

Contact name:

Sally Jones

Group Company Secretary

Telephone number:

01482 602595

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
FEESSMFDDFUSEFI
Date   Source Headline
5th Jun 20187:31 amRNSReplacement: Final Results
5th Jun 20187:00 amRNSFinal Results
4th Jun 20187:00 amRNSAppointment of interim Chief Financial Officer
21st May 201811:48 amRNSDirector/PDMR Shareholding
17th May 201812:00 pmRNSDirectorate Change
25th Apr 20187:00 amRNSDirector/PDMR Shareholding
15th Mar 201811:55 amRNSDirector/PDMR Shareholding
22nd Feb 201812:00 pmRNSManagement Succession
16th Feb 20184:03 pmRNSDirector/PDMR Shareholding
14th Feb 201812:09 pmRNSDirector/PDMR Shareholding
2nd Feb 201810:15 amRNSBlock listing Interim Review
1st Feb 20187:00 amRNSCapital Markets Day
30th Jan 20189:49 amRNSDirector/PDMR Shareholding
29th Jan 20187:00 amRNSTrading Update and Management Change
13th Dec 20173:02 pmRNSDirector/PDMR Shareholding
6th Dec 201710:30 amRNSHolding(s) in Company
28th Nov 20177:00 amRNSHalf-year Report
20th Nov 20177:00 amRNSDirector/PDMR Shareholding
3rd Nov 20171:30 pmRNSNotice of Results
12th Oct 20172:28 pmRNSDirector/PDMR Shareholding
13th Sep 20174:09 pmRNSDirector/PDMR Shareholding
24th Aug 20175:35 pmRNSDirector/PDMR Shareholding
14th Aug 201711:26 amRNSDirector/PDMR Shareholding
1st Aug 20177:00 amRNSBlock listing Interim Review
21st Jul 20174:25 pmRNSResult of AGM
21st Jul 20177:00 amRNSTrading Update
18th Jul 20174:41 pmRNSDirector/PDMR Shareholding
10th Jul 20176:20 pmRNSDirector/PDMR Shareholding
22nd Jun 20171:33 pmRNSAnnual Financial Report
21st Jun 201711:53 amRNSHolding(s) in Company
16th Jun 201711:08 amRNSDirector/PDMR Shareholding
12th Jun 20174:21 pmRNSNotice of AGM
6th Jun 20177:00 amRNSFinal Results
30th May 20177:00 amRNSChange of Adviser
25th May 201711:37 amRNSHolding(s) in Company
23rd May 20174:47 pmRNSHolding(s) in Company
22nd May 201712:02 pmRNSHolding(s) in Company
11th May 20174:02 pmRNSDirector/PDMR Shareholding
28th Apr 201710:46 amRNSDirector Declaration
20th Apr 20177:00 amRNSHolding(s) in Company
20th Apr 20177:00 amRNSHolding(s) in Company
12th Apr 20171:29 pmRNSDirector/PDMR Shareholding
12th Apr 20171:16 pmRNSHolding(s) in Company
10th Apr 20174:41 pmRNSHolding(s) in Company
17th Mar 20174:15 pmRNSDirector/PDMR Shareholding
15th Feb 20179:13 amRNSDirector/PDMR Shareholding
9th Feb 20177:00 amRNSDirector/PDMR Shareholding
3rd Feb 20173:34 pmRNSBlock listing Interim Review
26th Jan 20174:42 pmRNSHolding(s) in Company
17th Jan 201710:28 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.